原创《氨溴索在辅助治疗新生儿肺炎中作用安全性》：这是一篇与新生儿肺炎论文范文相关的免费优秀学术论文范文资料,为你的论文写作提供参考。
[摘 要] 目的 探讨对新生儿肺炎患儿行氨溴索辅助治疗的临床效果.方法 方便选取2015年4月—2016年4月该院收治的94例新生儿肺炎患儿作为研究对象,根据抛硬币法进行分组,正面为对照组,反面为实验组,各47例.对照组行常规抗感染药物治疗,实验组在常规抗感染治疗的基础上加用沐舒坦辅助治疗,观察并比较两组的治疗效果以及不良反应的发生情况.结果 实验组治疗有效率44例（93.62%）显著高于对照组33例（70.21%）,且对比差异有统计学意义（P<0.05）.实验组发生不良反应几率4例（8.51%）显著低于对照组12例（25.53%）,且对比差异有统计学意义（P<0.05）.结论 对新生儿肺炎患儿给药沐舒坦辅助治疗,能够降低患儿发生不良反应的几率,在一定程度上更加有效缓解患儿的不良症状,治疗效果十分显著.
[关键词] 不同药物；新生儿；肺炎；治疗效果；安全性
[中图分类号] R722 [文献标识码] A [文章编号] 1674-0742（2017）04（a）-0137-03
Effect of Ambroxol in the Adjunctive Treatment of Newborns with Pneumonia and Study on Safety
QI Zhi-hua, SHI Hai-yang
Department of Pediatrics, Hospital of Laiwu Steel Group, Laiwu, Shandong Province, 271126 China
[Abstract] Objective To study the clinical effect of ambroxol in the adjunctive treatment of newborns with pneumonia and study on safety. Methods Convenient selection 94 cases of newborns with pneumonia admitted and treated in our hospital from April 2015 to April 2016 were selected and randomly divided into two groups with 47 cases in each, the control group adopted the routine anti-infection drugs, while the experimental group adopted the adjunctive treatment of mucosolvan on the basis of the group, and the treatment effect and occurrence of adverse reactions were compared between the two groups. Results The treatment effective rate in the experimental group was obviously higher than that in the control group, （44 cases vs 33 cases, 93.62% vs 70.21%）, and the difference was statistically significant（P<0.05）, and the incidence rate of adverse reactions in the experimental group was obviously lower than that in the control group, （4 cases vs 12 cases, 8.51% vs 25.53%）, and the difference was statistically significant（P<0.05）. Conclusion The adjunctive treatment of mucosolvan for newborns with pneumonia can reduce the incidence rate of adverse reactions of children and effectively relieve the adverse symptoms of children, and the treatment effect is very obvious.
[Key words] Different drugs； Newborns； Pneumonia； Treatment effect； Safety
發生新生儿肺炎疾病的原因十分复杂,通常是由于新生儿体质较弱以及感染等因素所引发,存在排痰困难等不良症状,严重时将会造成新生儿重度窒息.肺炎患儿临床症状主要表现为：口吐白沫、呼吸功能异常、口唇发紫以及精神不振等,若不给予及时救治,将会严重影响新生儿的身体健康和未来发育,容易出现反复发病的不良症状[1].目前,沐舒坦是一种常用祛痰药物,可改善新生儿痰液粘稠症状,促进痰液排出,保存呼吸道通畅,增加抗生素在患儿肺内的浓度等治疗作用,对于新生儿肺炎的治疗效果十分显著[2].由此,该研究方便选取2015年4月—2016年4月该院收治的94例新生儿肺炎患儿作为研究对象,现报道如下.
1 资料和方法
1.1 一般资料
方便选取该院收治的94例新生儿肺炎患儿作为研究对象,根据抛硬币法进行分组,正面为对照组,反面为实验组,各47例.其中,实验组男性27例,女性20例,年龄为5～28 d,平均年龄（17.5±2.5）d,病程3～8 d,平均病程（4.4±1.7）d；对照组男性25例,女性22例,年龄为3～27 d,平均年龄（16.5±1.8）d,病程1.5～7.5 d,平均病程（4.2±1.4）d.两组患儿的基线资料比较差异无统计学意义（P>0.05）,研究可进行.
新生儿肺炎论文参考资料：
结论：氨溴索在辅助治疗新生儿肺炎中作用安全性为适合新生儿肺炎论文写作的大学硕士及相关本科毕业论文，相关新生儿肺炎多久能治好开题报告范文和学术职称论文参考文献下载。
